JPH07291848A - Skin aging-preventing cosmetic - Google Patents

Skin aging-preventing cosmetic

Info

Publication number
JPH07291848A
JPH07291848A JP10749794A JP10749794A JPH07291848A JP H07291848 A JPH07291848 A JP H07291848A JP 10749794 A JP10749794 A JP 10749794A JP 10749794 A JP10749794 A JP 10749794A JP H07291848 A JPH07291848 A JP H07291848A
Authority
JP
Japan
Prior art keywords
skin
vitamin
effect
cosmetic
bone marrow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10749794A
Other languages
Japanese (ja)
Inventor
Mikio Hashimoto
三喜男 橋本
Tatsu Miyamoto
達 宮本
Shigeru Aoyanagi
繁 青柳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP10749794A priority Critical patent/JPH07291848A/en
Publication of JPH07291848A publication Critical patent/JPH07291848A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PURPOSE:To prepare the skin aging-preventing cosmetic containing at least one kind selected from a bovine bone marrow extract, vitamin E or its ester, and diisopropylamine dichloroacetate. CONSTITUTION:This skin aging-preventing agent contains at least one kind selected from 0.001-10wt.% (based on the whole amount of the cosmetic) of a bovine bone marrow extract, 0.005-2wt.% of vitamin E or its ester compound, and 0.1-2wt.% of diisopropylamine dichloroacetate. The ingredients synergistically act on the skin to dilate skin peripheral blood vessels, stimulate skin functions, prevent skin wrinkles, and form a strong and fine skin. Simultaneously, an excellent rough skin-improving effect, a keratin-improving effect, and a turnover rate-increasing effect can be manifested in a short time and are maintained. The cosmetic can be prepared into a cream, an emulsion, a beauty wash, a pack, etc.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は皮膚老化防止化粧料(皮
膚の老化防止に用いる化粧料)に関する。さらに詳しく
は、皮膚老化防止効果(荒れ肌改善効果、角質改善効
果、ターンオーバー速度を早くする効果、美肌効果等)
の優れた皮膚老化防止化粧料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin aging-preventing cosmetic (a cosmetic used to prevent skin aging). More specifically, skin aging prevention effect (rough skin improvement effect, keratin improvement effect, effect of accelerating turnover speed, skin beauty effect, etc.)
Relating to excellent skin anti-aging cosmetics.

【0002】[0002]

【従来の技術および発明が解決しようとする課題】老化
皮膚とは、乾燥して滑らかさのない荒れ肌で、角質細胞
剥離現象が認められる皮膚である。そして老化皮膚は、
ターンオーバー速度が遅く、また皮膚に老化防止効果が
付与発現するとターンオーバー速度が早くなると言われ
ている。
2. Description of the Related Art Aged skin is dry skin that is not smooth and has keratinocyte exfoliation phenomenon. And aging skin
It is said that the turnover speed is slow, and when the antiaging effect is imparted to the skin, the turnover speed is increased.

【0003】本発明者らは、先に、牛の骨髄エキスが皮
膚が本来備えている水分保持機能を亢進することによっ
て、皮膚を健常な状態に保持しあるいは修復して皮膚に
湿潤性、柔軟性、弾力性および艶を与え、優れた美肌効
果を見出し、特に、老化皮膚に適用した場合にはその効
果が顕著に認められることから、老化防止効果を有する
ことを見出し、提案した(特開昭63−66108号公
報)。
The present inventors have previously found that the bone marrow extract of cattle enhances the water-retaining function originally possessed by the skin to maintain or restore the skin in a healthy state, thereby making the skin wettable and soft. To impart elasticity, elasticity and luster and find an excellent skin-beautifying effect. Especially, when applied to aged skin, the effect is remarkably observed. 63-66108).

【0004】また、ビタミンEおよびそのエステル化合
物は血管拡張作用があるので凍傷、侵出性抗紅斑、霜焼
け等の治療に用いられており、牛の骨髄エキスと同様に
皮膚機能を亢進し、老化防止効果を有することが、期待
される。
Further, since vitamin E and its ester compound have a vasodilatory effect, they are used for the treatment of frostbite, exudative antierythema, frostburn, etc., and like the bone marrow extract of cattle, they promote skin function and aging. It is expected to have a preventive effect.

【0005】一方、ジイソプロピルアミンジクロロアセ
テートは、公知の物質で、皮膚組織賦活作用により皮膚
機能を亢進し、皮膚老化防止効果を有することが提案
(特公昭62−18523号公報)されている。
On the other hand, diisopropylamine dichloroacetate is a known substance, and it has been proposed (Japanese Patent Publication No. 62-18523) to enhance the skin function by activating the skin tissue and have the effect of preventing skin aging.

【0006】しかし、これらの皮膚機能を亢進する成分
である皮膚賦活剤を単独で配合してなる皮膚化粧料は、
いずれも老化防止等の効果は遅効性で、効果が現れるま
でに時間を要するため、十分満足し得るものではなく、
改良の余地を残しているのが実情であった。
[0006] However, the skin cosmetics containing the skin activating agent, which is a component for enhancing these skin functions, alone are
In both cases, the effects such as aging prevention are delayed, and it takes time for the effects to appear, so they are not sufficiently satisfactory,
The reality is that there is room for improvement.

【0007】本発明者らは、このような実情に鑑み、優
れた皮膚老化防止効果(荒れ肌改善効果、角質改善効
果、ターンオーバー速度を早くする効果、美肌効果等)
が、使用開始後1ケ月目という極く短時間に発現し、か
つ持続する速効性の皮膚老化防止化粧料がないものかと
鋭意研究を重ねた結果、牛の骨髄エキスと、ビタミンE
およびそのエステル化合物、ジイソプロピルアミンジク
ロロアセテートの群から選ばれた少なくとも一種とを配
合することによって、相乗効果により、この目的が達成
されることを見出して本発明を完成するに至った。
In view of such circumstances, the present inventors have an excellent effect of preventing skin aging (effect of improving rough skin, effect of improving keratin, effect of accelerating turnover speed, effect of beautiful skin, etc.).
However, as a result of extensive research into whether there is a rapid-acting skin anti-aging cosmetic that appears for a very short period of time, which is the first month after the start of use, as a result, bovine bone marrow extract and vitamin E have been obtained.
The present invention has been completed by finding that this object can be achieved by a synergistic effect by blending the compound and its ester compound, and at least one selected from the group of diisopropylamine dichloroacetate.

【0008】[0008]

【課題を解決するための手段】すなわち、本発明は、ビ
タミンEおよびそのエステル化合物、ジイソプロピルア
ミンジクロロアセテートの群から選ばれた少なくとも一
種と、牛の骨髄エキスとを配合することを特徴とする皮
膚老化防止化粧料を提供するものである。
That is, the present invention is characterized in that at least one selected from the group of vitamin E and its ester compound, diisopropylamine dichloroacetate, and bovine bone marrow extract are blended. An anti-aging cosmetic is provided.

【0009】以下、本発明の構成について詳述する。上
記の目的を達成するために、本発明の皮膚老化防止化粧
料は、ビタミンEおよびそのエステル化合物、ジイソプ
ロピルアミンジクロロアセテートの群から選ばれた少な
くとも一種と、牛の骨髄エキスとを配合することを特徴
とするものである。
The structure of the present invention will be described in detail below. In order to achieve the above-mentioned object, the skin anti-aging cosmetic composition of the present invention contains at least one selected from the group consisting of vitamin E and its ester compound, diisopropylamine dichloroacetate, and bovine bone marrow extract. It is a feature.

【0010】本発明に用いるビタミンEおよびそのエス
テル化合物は公知の物質であって、たとえばビタミン
E、ビタミンEアセテート、ビタミンEニコチネート、
ビタミンEサクシネート、ビタミンEリノレート、ビタ
ミンEオロテート等が挙げられる。ビタミンEとは、α
−トコフェロール、β−トコフェロール、γ−トコフェ
ロール、δ−トコフェロール等、あるいはその混合物を
指す。これらのビタミンEおよびそのエステル化合物
は、いずれも本発明の老化予防化粧料に適用することが
でき、それぞれ単独、もしくはその二つ以上の混合物と
して老化予防化粧料に配合される。
Vitamin E and its ester compound used in the present invention are known substances such as vitamin E, vitamin E acetate, vitamin E nicotinate,
Vitamin E succinate, vitamin E linoleate, vitamin E orotate and the like can be mentioned. What is Vitamin E?
-Tocopherol, β-tocopherol, γ-tocopherol, δ-tocopherol, etc., or a mixture thereof. Any of these vitamin E and its ester compound can be applied to the anti-aging cosmetic composition of the present invention, and they are each incorporated alone or as a mixture of two or more thereof in the anti-aging cosmetic composition.

【0011】また、本発明に用いるビタミンEおよびそ
のエステル化合物は抗酸化作用を有するので、牛の骨髄
エキス、他の配合成分の劣化を抑制することも期待され
る。
Further, since the vitamin E and its ester compound used in the present invention have an antioxidant effect, it is expected that the deterioration of bovine bone marrow extract and other components is suppressed.

【0012】ビタミンEおよびそのエステル化合物の配
合量は、本発明の目的を達成できる範囲を検討した結
果、化粧料の処方成分全量を基準として、0.005〜
2.0重量%である。
The amount of vitamin E and its ester compound to be blended is 0.005 based on the total amount of the prescription components of the cosmetic as a result of studying the range in which the object of the present invention can be achieved.
It is 2.0% by weight.

【0013】本発明に用いる、ジイソプロピルアミンジ
クロロアセテートについては、前記公報に詳細に記載さ
れている。以下、ジイソプロピルアミンジクロロアセテ
ートはDADAと略する。
The diisopropylamine dichloroacetate used in the present invention is described in detail in the above publication. Hereinafter, diisopropylamine dichloroacetate is abbreviated as DADA.

【0014】DADAの配合量は、本発明の目的を達成
できる範囲を検討した結果、化粧料の処方成分全量を基
準として、0.1〜2.0重量%である。
As a result of studying the range in which the object of the present invention can be achieved, the content of DADA is 0.1 to 2.0% by weight based on the total amount of the prescription components of the cosmetic.

【0015】本発明に適用される牛の骨髄エキスの抽出
法はつぎの通りである。すなわち、粉砕した牛の背骨、
寛骨、大腿骨100kgに500リットルのアセトンを加
え1時間攪拌した後、濾過した。この残渣にメタノール
100リットル、クロロホルム200リットルを加えて
4時間攪拌した後濾過した。残渣にさらにクロロホルム
−メタノール混合液を200リットルを加え50℃に保
温し2時間抽出を行った後、濾別し、上記の各抽出液に
合併した。この抽出液をロータリーエバポレーターによ
り蒸発乾固し、牛の骨髄エキス8.6kgを得た。このも
のの、分析結果は以下の通りである。: 脂質 :87.8% タンパク質 : 3.6% 灰分 : 0.3% 糖質 : 0.4% 水分 : 7.9% 全窒素 : 0.6%
The extraction method of bovine bone marrow extract applied to the present invention is as follows. That is, the crushed cow spine,
To 100 kg of hip bone and femur, 500 liter of acetone was added, stirred for 1 hour, and then filtered. To this residue, 100 liters of methanol and 200 liters of chloroform were added, stirred for 4 hours and then filtered. To the residue was added 200 liters of a chloroform-methanol mixture, the temperature was kept at 50 ° C., the mixture was extracted for 2 hours, then filtered and combined with each of the above extracts. The extract was evaporated to dryness with a rotary evaporator to obtain 8.6 kg of bovine bone marrow extract. However, the analysis results are as follows. : Lipid: 87.8% Protein: 3.6% Ash: 0.3% Carbohydrate: 0.4% Moisture: 7.9% Total nitrogen: 0.6%

【0016】牛の骨髄エキスの配合量は、本発明の目的
を達成できる範囲を検討した結果、化粧料の処方成分全
量を基準として、乾燥残分に換算して0.001〜1
0.0重量%である。
The amount of bovine bone marrow extract blended was 0.001 to 1 in terms of dry residue, based on the total amount of the prescription components of the cosmetic, as a result of studying the range in which the object of the present invention can be achieved.
It is 0.0% by weight.

【0017】本発明の皮膚老化防止化粧料は、前述の如
く、牛の骨髄エキスと、ビタミンEおよびそのエステル
化合物、DADAの群から選ばれた少なくとも一種とを
配合することを特徴とするものであって、これらが相乗
的に皮膚に作用して、皮膚の末梢血管を拡張し、皮膚機
能を亢進して、肌のしわを防止し、肌目(きめ)こまか
なかつしっかりとした皮膚にする(美肌効果)と共に、
優れた皮膚老化防止効果(荒れ肌改善効果、角質改善効
果、ターンオーバー速度を早くする効果)を短時間に発
現し、持続する等、顕著な効果を現す。
As described above, the skin anti-aging cosmetic composition of the present invention is characterized by blending bovine bone marrow extract with at least one selected from the group consisting of vitamin E, its ester compound and DADA. So, these act synergistically on the skin, expand peripheral blood vessels of the skin, enhance skin function, prevent wrinkles of the skin, and make the skin fine and firm (( (Beautiful skin effect)
It exerts outstanding effects of preventing skin aging (rough skin improving effect, keratin improving effect, effect of accelerating turnover speed) in a short period of time and lastingly.

【0018】本発明の化粧料には、上記原料の他にター
ル系色素、酸化鉄などの着色顔料、パラベンなどの防腐
剤、脂肪酸セッケン、セチル硫酸ナトリウムなどの陰イ
オン界面活性剤、ポリオキシエチレンアルキルエーテ
ル、ポリオキシエチレン脂肪酸エステル、ポリオキシエ
チレン多価アルコール脂肪酸エステル、ポリオキシエチ
レン硬化ヒマシ油、多価アルコール脂肪酸エステル、ポ
リグリセリン脂肪酸エステルなどの非イオン界面活性
剤、テトラアルキルアンモニウム塩などの陽イオン界面
活性剤、ベタイン型、スルホベタイン型、スルホアミノ
酸型、N−ステアロイル−L−グルタミン酸ナトリウム
などの両性界面活性剤、レシチン、リゾフォスファチジ
ルコリンなどの天然系界面活性剤、酸化チタンなどの顔
料、ジブチルヒドロキシトルエンなどの抗酸化剤など
を、本発明の目的を達成する範囲内で適宜配合すること
ができる。
In the cosmetics of the present invention, in addition to the above-mentioned raw materials, tar pigments, coloring pigments such as iron oxide, preservatives such as parabens, fatty acid soaps, anionic surfactants such as sodium cetylsulfate, polyoxyethylene. Nonionic surfactants such as alkyl ethers, polyoxyethylene fatty acid esters, polyoxyethylene polyhydric alcohol fatty acid esters, polyoxyethylene hydrogenated castor oil, polyhydric alcohol fatty acid esters, polyglycerin fatty acid esters, tetraalkylammonium salts, etc. Ionic surfactants, betaine-type, sulfobetaine-type, sulfoamino acid-type, amphoteric surfactants such as sodium N-stearoyl-L-glutamate, natural surfactants such as lecithin and lysophosphatidylcholine, and titanium oxide Pigment, dibutyl hydroxy And antioxidants such as toluene, may be appropriately blended within the range to achieve the object of the present invention.

【0019】本発明の化粧料の剤型としては、クリー
ム、乳液、化粧水、パックなどが挙げられる。
The dosage form of the cosmetic of the present invention includes creams, emulsions, lotions, packs and the like.

【0020】[0020]

【実施例】以下、実施例および比較例により本発明を詳
細に説明するが、本発明はこれらに限定されるものでは
ない。なお、本発明に使用した試験方法は下記の通りで
ある。
The present invention will be described in detail below with reference to examples and comparative examples, but the present invention is not limited to these. The test method used in the present invention is as follows.

【0021】角質層のターンオーバー速度測定方法 蛍光色素のダンシルクロリドを白色ワセリン中に5重量
%配合した軟膏を作り、被験者の前腕部の皮膚に24時
間閉塞塗布し、角質層にダンシルクロリドを浸透結合さ
せた。その後、同じ部位に1日2回(朝、夕)被験試料
を塗布し、毎日ダンシルクロリドの蛍光を調べ、その蛍
光が消滅するまでの日数を皮膚角質層のターンオーバー
速度とした。
Method for measuring turnover rate of stratum corneum An ointment was prepared by mixing 5% by weight of fluorescent dye dansyl chloride in white petrolatum, and applied occlusion on the skin of the forearm of a subject for 24 hours, and the horny layer was penetrated with dansyl chloride. Combined. Thereafter, the test sample was applied to the same site twice a day (morning and evening), and the fluorescence of dansyl chloride was examined every day. The number of days until the fluorescence disappeared was defined as the turnover rate of the stratum corneum of the skin.

【0022】荒れ肌改善効果の測定試験法 下脚に荒れ肌を有する中高年被験者20名を対象として
4週間連続塗布効果を調べた。被験者の左側脚試験部位
に1日2回約1g の試料を塗布し、試験開始前および終
了後の皮膚の状態を下記の判定基準により判定した。な
お、右側下脚は試料を塗布せず対象とした。 皮膚乾燥度の判定基準 − :正常 ± :軽微乾燥、落屑なし + :乾燥、落屑軽度 ++ :乾燥、落屑中等度 +++:乾燥、落屑顕著 試験前後の試験部位と対照部位の判定結果を比較し、皮
膚乾燥度が2段階以上改善された場合(例えば+→−,
++→±)を「有効」、1段階改善された場合を「やや
有効」、変化がなかった場合を「無効」とした。試験結
果は「有効」、「やや有効」となった被験者の人数で示
した。
Measurement Test Method for Rough Skin Improvement Effect The effect of continuous application for 4 weeks was investigated for 20 middle-aged and elderly subjects who have rough skin on their lower legs. About 1 g of the sample was applied to the test site of the left leg of the test subject twice a day, and the condition of the skin before and after the start of the test was evaluated according to the following criteria. The right lower leg was used as a target without applying the sample. Criteria for skin dryness −: Normal ±: Minor dryness, no desquamation +: Dry, mild desquamation ++: Dry, moderate desquamation +++: Dryness, remarkable desquamation Compare the determination results of the test site before and after the test and the control site, When the skin dryness is improved by two or more stages (for example, + →-,
++ → ±) is defined as “valid”, a case of improvement by 1 level is defined as “slightly valid”, and a case of no change is defined as “invalid”. The test results are shown by the number of subjects who were “effective” and “somewhat effective”.

【0023】角質改善(角質細胞の抗剥離性増大)効
果の測定試験法 前述の荒れ肌改善測定試験開始前および終了後の被験部
皮膚にスコッチテープ(ニチバンメンディングテープ)
を接着し、これを剥離した時テープに付着した角質細胞
の状態を走査型電子顕微鏡によって詳細に調べ、下記の
判定基準によって皮膚角質層細胞剥離性を分類し、角質
改善効果を求めた。 角質改善(角質細胞の抗剥離性増大)効果の判定基準 評価点1:スケールを認めず 評価点2:小スケール点在 評価点3:小〜中スケール顕著 評価点4:大スケール顕著 判定は4週間連続塗布後の試験部位の評価点と対照部位
のそれとの差が2点以上の場合を「有効」、1点の場合
を「やや有効」、0点の場合を「無効」とした。試験結
果は「有効」、「やや有効」となった被験者の人数で示
した。
Test method for measuring the effect of improving keratin (increasing the anti-peeling property of keratinocytes) Scotch tape (Nichiban Mending Tape) on the skin of the test area before and after the start of the rough skin improvement measurement test described above
The state of keratinocytes adhering to the tape was peeled off and the state of the keratinocytes adhered to the tape was examined in detail by a scanning electron microscope. Criteria for improving keratin (increasing anti-peeling properties of keratinocytes) Evaluation point 1: No scale is recognized Evaluation point 2: Small scale interspersed evaluation point 3: Small to medium scale outstanding Evaluation point 4: Large scale outstanding When the difference between the evaluation points of the test site after weekly continuous application and that of the control site was 2 points or more, "effective" was given, 1 point was "somewhat effective", and 0 point was "ineffective". The test results are shown by the number of subjects who were “effective” and “somewhat effective”.

【0024】官能テスト(素肌効果試験) 荒れ肌、小じわ、乾燥肌等を訴える女子被験者(35〜
55才)20人に試料を1日2回(朝、夕)連続3ケ月
間塗布して、1、2、3ケ月後の効果を評価した。試験
結果は、皮膚の湿潤性、平滑性、弾力性の各項目に対し
て、「皮膚に潤いが生じた」、「皮膚が滑らかになっ
た」、「皮膚に張りが生じた」と回答した人数で示し
た。
Sensory test (bare skin effect test) Female subjects who complain of rough skin, fine wrinkles, dry skin (35-35)
The sample was applied to 20 people (55 years old) twice a day (morning and evening) for 3 consecutive months, and the effect after 1, 2 and 3 months was evaluated. The test results replied that "the skin was moisturized", "the skin was smooth", and "the skin was tense" with respect to each item of the skin wettability, smoothness, and elasticity. The number of people is shown.

【0025】実施例1〜4、比較例1〜4[スキンクリ
ーム] 牛の骨髄エキスとビタミンEおよびそのエステル化合物
を表2、3に記載の通りに配合し、表1の組成で各々の
スキンクリームを調製し、前記の諸実験を実施した。な
お、ビタミンEはVE、ビタミンEアセテートはVE−
A、ビタミンEニコチネートはVE−Nのごとく略記す
る。 (1)組成
Examples 1 to 4, Comparative Examples 1 to 4 [Skin cream] Bovine bone marrow extract, vitamin E and its ester compound were blended as shown in Tables 2 and 3, and each skin was prepared with the composition shown in Table 1. Creams were prepared and the above experiments were carried out. Vitamin E is VE, Vitamin E acetate is VE-
A, vitamin E nicotinate is abbreviated as VE-N. (1) Composition

【0026】[0026]

【表1】 [Table 1]

【0027】(2)調製法 (A)成分および(B)成分を各々80℃に加熱溶解し
た後混合して、攪拌しつつ30℃まで冷却して、各スキ
ンクリームを調製した。
(2) Preparation Method Each of the components (A) and (B) was heated and dissolved at 80 ° C., then mixed and cooled to 30 ° C. with stirring to prepare each skin cream.

【0028】(3)特性 各スキンクリームの諸試験を実施した結果を表2〜4に
記載した。
(3) Characteristics Tables 2 to 4 show the results of various tests conducted on each skin cream.

【0029】[0029]

【表2】 [Table 2]

【0030】[0030]

【表3】 [Table 3]

【0031】[0031]

【表4】 [Table 4]

【0032】表2〜4に示すごとく、比較例1〜4の牛
の骨髄エキス、ビタミンEおよびそのエステル化合物を
単独で配合したスキンクリームは諸特性において十分な
効果は得られず、本発明の実施例1〜4の牛の骨髄エキ
スとビタミンEおよびそのエステル化合物の群から選ば
れる少なくとも1種を配合したスキンクリームは諸特性
において顕著な効果が見られ、官能テストでは試料塗布
後1〜2ケ月で優れた美肌効果を示した。
As shown in Tables 2 to 4, the skin creams of Comparative Examples 1 to 4 in which the bovine bone marrow extract, vitamin E and the ester compound thereof were blended alone did not show sufficient effects in various characteristics, and thus the skin creams of the present invention were obtained. The skin creams of Examples 1 to 4 in which the bovine bone marrow extract and at least one selected from the group of vitamin E and its ester compound were mixed showed remarkable effects in various properties. It showed an excellent skin-beautifying effect for a month.

【0033】実施例5、6[スキンローション] 下記の組成において各々のスキンローションを調製して
諸試験を実施した。 (1)組成
Examples 5 and 6 [Skin lotion] Each skin lotion having the following composition was prepared and various tests were carried out. (1) Composition

【0034】[0034]

【表5】 [Table 5]

【0035】(2)調製法 (A)、(B)成分を各々均一に溶解した後、(A)成
分と(B)成分を混合攪拌分散し、ついで容器に充填し
た。使用時には内容物を均一に振盪分散して使用した。
(2) Preparation Method After the components (A) and (B) were uniformly dissolved, the component (A) and the component (B) were mixed and dispersed by stirring, and then filled in a container. At the time of use, the content was uniformly dispersed by shaking before use.

【0036】(3)特性 実施例5、6は、前記諸試験においてすべて良好な結果
を示した。
(3) Characteristics Examples 5 and 6 all showed good results in the above tests.

【0037】実施例7〜10、比較例5〜7[スキンク
リーム] 牛の骨髄エキスとDADAを表7、8に記載の通りに配
合し、表6の組成で各々のスキンクリームを調製し、前
記の諸実験を実施した。 (1)組成
Examples 7 to 10 and Comparative Examples 5 to 7 [Skin cream] Bovine bone marrow extract and DADA were blended as shown in Tables 7 and 8 to prepare each skin cream with the composition shown in Table 6, The above experiments were carried out. (1) Composition

【0038】[0038]

【表6】 [Table 6]

【0039】(2)調製法 (A)成分および(B)成分を各々80℃に加熱溶解し
た後混合して、攪拌しつつ30℃まで冷却して、各スキ
ンクリームを調製した。
(2) Preparation Method Each of the components (A) and (B) was heated and dissolved at 80 ° C., then mixed and cooled to 30 ° C. with stirring to prepare each skin cream.

【0040】(3)特性 各スキンクリームの諸試験を実施した結果を表7〜9に
記載した。
(3) Properties The results of various tests of each skin cream are shown in Tables 7-9.

【0041】[0041]

【表7】 [Table 7]

【0042】[0042]

【表8】 [Table 8]

【0043】[0043]

【表9】 [Table 9]

【0044】表7〜9に示すごとく、比較例5〜7の牛
の骨髄エキス、DADAを単独で配合したスキンクリー
ムは諸特性において十分な効果は得られず、本発明の実
施例7〜10の牛の骨髄エキスとDADAを配合したス
キンクリームは諸特性において顕著な効果が見られ、官
能テストでは試料塗布後1〜2ケ月で優れた美肌効果を
示した。
As shown in Tables 7-9, the skin creams of Comparative Examples 5-7 in which the bovine bone marrow extract and DADA were blended alone did not show sufficient effects in various properties, and the skin creams of Examples 7-10 of the present invention were obtained. The skin cream containing the bovine bone marrow extract and DADA showed remarkable effects on various properties, and a sensory test showed excellent skin-beautifying effect 1-2 months after application of the sample.

【0045】実施例11、12[スキンローション] 下記の組成において各々のスキンローションを調製して
諸試験を実施した。 (1)組成
Examples 11 and 12 [Skin lotion] Each skin lotion having the following composition was prepared and various tests were carried out. (1) Composition

【0046】[0046]

【表10】 [Table 10]

【0047】(2)調製法 (A)、(B)成分を各々均一に溶解した後、(A)成
分と(B)成分を混合攪拌分散し、ついで容器に充填し
た。使用時には内容物を均一に振盪分散して使用した。
(2) Preparation method After the components (A) and (B) were uniformly dissolved, the components (A) and (B) were mixed and stirred to be dispersed, and then filled in a container. At the time of use, the content was uniformly dispersed by shaking before use.

【0048】(3)特性 実施例11、12は、前記諸試験においてすべて良好な
結果を示した。
(3) Characteristics Examples 11 and 12 all showed good results in the above-mentioned tests.

【0049】[0049]

【発明の効果】以上記載のごとく、本発明が、皮膚老化
防止効果(荒れ肌改善効果、角質改善効果、ターンオー
バー速度を早くする効果、美肌効果等)の優れた有用な
る皮膚老化防止化粧料を提供することは明らかである。
Industrial Applicability As described above, the present invention provides a useful skin anti-aging cosmetic having excellent anti-aging effects (rough skin improving effect, keratin improving effect, turnover speed increasing effect, beautiful skin effect, etc.). It is clear to provide.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 ビタミンEおよびそのエステル化合物、
ジイソプロピルアミンジクロロアセテートの群から選ば
れた少なくとも一種と、牛の骨髄エキスとを配合するこ
とを特徴とする皮膚老化防止化粧料。
1. Vitamin E and its ester compound,
A skin anti-aging cosmetic composition comprising at least one selected from the group of diisopropylamine dichloroacetate and bovine bone marrow extract.
JP10749794A 1994-04-21 1994-04-21 Skin aging-preventing cosmetic Pending JPH07291848A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10749794A JPH07291848A (en) 1994-04-21 1994-04-21 Skin aging-preventing cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10749794A JPH07291848A (en) 1994-04-21 1994-04-21 Skin aging-preventing cosmetic

Publications (1)

Publication Number Publication Date
JPH07291848A true JPH07291848A (en) 1995-11-07

Family

ID=14460714

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10749794A Pending JPH07291848A (en) 1994-04-21 1994-04-21 Skin aging-preventing cosmetic

Country Status (1)

Country Link
JP (1) JPH07291848A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160000142A (en) * 2014-06-24 2016-01-04 강원대학교산학협력단 Method for production of horse leg bone extract and cosmetic composition with the extract of horse leg bone
KR20180080736A (en) * 2017-01-04 2018-07-13 강원대학교산학협력단 Cosmetic composition with small molecule gelatin peptide from donkey bone for anti-wrinkle and anti-aging of skin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160000142A (en) * 2014-06-24 2016-01-04 강원대학교산학협력단 Method for production of horse leg bone extract and cosmetic composition with the extract of horse leg bone
KR20180080736A (en) * 2017-01-04 2018-07-13 강원대학교산학협력단 Cosmetic composition with small molecule gelatin peptide from donkey bone for anti-wrinkle and anti-aging of skin

Similar Documents

Publication Publication Date Title
RU2461372C1 (en) Emulsion cosmetic composition
JPH1160434A (en) Cosmetic for preventing skin aging
KR20210148875A (en) LOW pH SKIN CARE COMPOSITION AND METHODS OF USING THE SAME
JPH10130135A (en) Cosmetic for preventing aging of skin
JP3193542B2 (en) Anti-aging skin cosmetics
JPH0733637A (en) Skin cosmetic
JPH1129457A (en) Skin cosmetic
JP2001010946A (en) Skin cosmetic
JPH07291848A (en) Skin aging-preventing cosmetic
JPS60184005A (en) Cosmetic for preventing aging of skin
JPH11180851A (en) Skin cosmetic
JPH07118140A (en) Cosmetic for preventing aging of skin
JPH1160462A (en) Skin cosmetic
JPH1112156A (en) Emulsion composition
JP3441166B2 (en) Anti-aging skin cosmetics
JP3534934B2 (en) Skin cosmetics
JPH06256155A (en) Skin aging-preventing cosmetic
JP3556479B2 (en) Skin pre-treatment agent
JP3532713B2 (en) Skin cosmetics
JP2000001421A (en) Cosmetic for preventing skin aging
JP3121957B2 (en) Anti-aging skin cosmetics
JP3534941B2 (en) Anti-aging skin cosmetics
JP3001942B2 (en) Skin cosmetics
JP2995014B2 (en) Skin cosmetics
KR0153203B1 (en) Cosmetic composition for moisturising and softening